Literature DB >> 6338806

Observations on the efficacy of propranolol for the prophylaxis of migraine.

J A Rosen.   

Abstract

Among 1,036 patients treated for migraine headache between 1973 and 1980, 865 were given a daily maximum dose of 320 mg of propranolol, while 171 served as differently treated controls. At least one year of treatment was prescribed, at the end of which time 84% of the propranolol group reported sustained improvement compared with similar improvement in only 32% of controls (p less than 0.01). The success rate progressively increased during the entire year.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338806     DOI: 10.1002/ana.410130119

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  11 in total

Review 1.  Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.

Authors:  Peer Tfelt-Hansen; Frederik Nybye Ågesen; Agniezka Pavbro; Jacob Tfelt-Hansen
Journal:  CNS Drugs       Date:  2017-05       Impact factor: 5.749

Review 2.  The severity model of chronic headache.

Authors:  M J Smith; N M Jensen
Journal:  J Gen Intern Med       Date:  1988 Jul-Aug       Impact factor: 5.128

Review 3.  WITHDRAWN: Drugs for preventing migraine headaches in children.

Authors:  Suresh Victor; Steven Ryan
Journal:  Cochrane Database Syst Rev       Date:  2014-07-11

Review 4.  Vascular headache.

Authors:  K L Kumar; T G Cooney
Journal:  J Gen Intern Med       Date:  1988 Jul-Aug       Impact factor: 5.128

5.  Migraine headaches in hydrocephalic children: a diagnostic dilemma.

Authors:  T P Nowak; H E James
Journal:  Childs Nerv Syst       Date:  1989-10       Impact factor: 1.475

Review 6.  Beneficial Extracardiac Effects of Cardiovascular Medications.

Authors:  Asra K Butt; Jay Patel; Hamid Shirwany; Qasim Mirza; Jonathan Hoover; Rami N Khouzam
Journal:  Curr Cardiol Rev       Date:  2022

7.  Results of a pilot multicenter genotype-based randomized placebo-controlled trial of propranolol to reduce pain after major thermal burn injury.

Authors:  Danielle C Orrey; Omar I Halawa; Andrey V Bortsov; Jeffrey W Shupp; Samuel W Jones; Linwood R Haith; Janelle M Hoskins; Marion H Jordan; Shrikant I Bangdiwala; Brandon R Roane; Timothy F Platts-Mills; James H Holmes; James Hwang; Bruce A Cairns; Samuel A McLean
Journal:  Clin J Pain       Date:  2015-01       Impact factor: 3.442

8.  [Therapy for migraine-the current state of the art and perspectives.].

Authors:  D Soyka
Journal:  Schmerz       Date:  1987-09       Impact factor: 1.107

Review 9.  Migraine.

Authors:  J G Edmeads
Journal:  CMAJ       Date:  1988-01-15       Impact factor: 8.262

Review 10.  Beta-adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine.

Authors:  K E Andersson; E Vinge
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.